Literature DB >> 1358601

A pituitary specific point mutation of codon 201 of the Gs alpha gene in a pituitary adenoma of a patient with multiple endocrine neoplasia (MEN) type 1.

E Hosoi1, Y Yokogoshi, E Hosoi1, K Yokoi, T Sano, S Saito.   

Abstract

The DNA from a pituitary adenoma of a patient with multiple endocrine neoplasia (MEN) type 1 was analyzed to detect a point mutation of the Gs alpha gene (gsp) by the PCR direct-sequencing method. The patient had galactorrhea, amenorrhea and acromegalic features. Hormonal examination revealed high serum levels of PRL and GH. The tumor was histologically diagnosed as a mixed GH cell-PRL cell adenoma in which GH and PRL were produced by different cells. Sequence analysis of the DNAs extracted from paraffin sections of pituitary, parathyroid, and pancreas tumors demonstrated the substitution of thymidine for cytidine in codon 201 of the Gs alpha gene that resulted in replacement of arginine (CGT) with cysteine (TGT) only in the pituitary adenoma, but not in the parathyroid and pancreas tumors. These results suggest that a pituitary specific point mutational activation of the Gs alpha gene may be involved in the development of the pituitary adenoma in this patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358601     DOI: 10.1507/endocrj1954.39.319

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  3 in total

Review 1.  Familial acromegaly: case report and review of the literature.

Authors:  A Verloes; A Stevenaert; B T Teh; P Petrossians; A Beckers
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Double pituitary adenomas: six surgical cases.

Authors:  T Sano; H Horiguchi; B Xu; C Li; A Hino; M Sakaki; S Kannuki; S Yamada
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

3.  Point mutations of ras and Gs alpha subunit genes in thyroid tumors.

Authors:  H Horie; Y Yokogoshi; M Tsuyuguchi; S Saito
Journal:  Jpn J Cancer Res       Date:  1995-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.